2022-12-012023-11-302023-11-30false03792193A.B. CHEMISTS LTD2024-08-27iso4217:GBPxbrli:pure037921932022-12-01037921932023-11-30037921932022-12-012023-11-30037921932021-12-01037921932022-11-30037921932021-12-012022-11-3003792193bus:SmallEntities2022-12-012023-11-3003792193bus:AuditExempt-NoAccountantsReport2022-12-012023-11-3003792193bus:FullAccounts2022-12-012023-11-3003792193bus:PrivateLimitedCompanyLtd2022-12-012023-11-3003792193core:WithinOneYear2023-11-3003792193core:AfterOneYear2023-11-3003792193core:WithinOneYear2022-11-3003792193core:AfterOneYear2022-11-3003792193core:ShareCapital2023-11-3003792193core:SharePremium2023-11-3003792193core:RevaluationReserve2023-11-3003792193core:OtherReservesSubtotal2023-11-3003792193core:RetainedEarningsAccumulatedLosses2023-11-3003792193core:ShareCapital2022-11-3003792193core:SharePremium2022-11-3003792193core:RevaluationReserve2022-11-3003792193core:OtherReservesSubtotal2022-11-3003792193core:RetainedEarningsAccumulatedLosses2022-11-3003792193core:LandBuildings2023-11-3003792193core:PlantMachinery2023-11-3003792193core:Vehicles2023-11-3003792193core:FurnitureFittings2023-11-3003792193core:OfficeEquipment2023-11-3003792193core:NetGoodwill2023-11-3003792193core:IntangibleAssetsOtherThanGoodwill2023-11-3003792193core:ListedExchangeTraded2023-11-3003792193core:UnlistedNon-exchangeTraded2023-11-3003792193core:LandBuildings2022-11-3003792193core:PlantMachinery2022-11-3003792193core:Vehicles2022-11-3003792193core:FurnitureFittings2022-11-3003792193core:OfficeEquipment2022-11-3003792193core:NetGoodwill2022-11-3003792193core:IntangibleAssetsOtherThanGoodwill2022-11-3003792193core:ListedExchangeTraded2022-11-3003792193core:UnlistedNon-exchangeTraded2022-11-3003792193core:LandBuildings2022-12-012023-11-3003792193core:PlantMachinery2022-12-012023-11-3003792193core:Vehicles2022-12-012023-11-3003792193core:FurnitureFittings2022-12-012023-11-3003792193core:OfficeEquipment2022-12-012023-11-3003792193core:NetGoodwill2022-12-012023-11-3003792193core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3003792193core:ListedExchangeTraded2022-12-012023-11-3003792193core:UnlistedNon-exchangeTraded2022-12-012023-11-3003792193core:MoreThanFiveYears2022-12-012023-11-3003792193core:Non-currentFinancialInstruments2023-11-3003792193core:Non-currentFinancialInstruments2022-11-3003792193dpl:CostSales2022-12-012023-11-3003792193dpl:DistributionCosts2022-12-012023-11-3003792193core:LandBuildings2022-12-012023-11-3003792193core:PlantMachinery2022-12-012023-11-3003792193core:Vehicles2022-12-012023-11-3003792193core:FurnitureFittings2022-12-012023-11-3003792193core:OfficeEquipment2022-12-012023-11-3003792193dpl:AdministrativeExpenses2022-12-012023-11-3003792193core:NetGoodwill2022-12-012023-11-3003792193core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3003792193dpl:GroupUndertakings2022-12-012023-11-3003792193dpl:ParticipatingInterests2022-12-012023-11-3003792193dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3003792193core:ListedExchangeTraded2022-12-012023-11-3003792193dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3003792193core:UnlistedNon-exchangeTraded2022-12-012023-11-3003792193dpl:CostSales2021-12-012022-11-3003792193dpl:DistributionCosts2021-12-012022-11-3003792193core:LandBuildings2021-12-012022-11-3003792193core:PlantMachinery2021-12-012022-11-3003792193core:Vehicles2021-12-012022-11-3003792193core:FurnitureFittings2021-12-012022-11-3003792193core:OfficeEquipment2021-12-012022-11-3003792193dpl:AdministrativeExpenses2021-12-012022-11-3003792193core:NetGoodwill2021-12-012022-11-3003792193core:IntangibleAssetsOtherThanGoodwill2021-12-012022-11-3003792193dpl:GroupUndertakings2021-12-012022-11-3003792193dpl:ParticipatingInterests2021-12-012022-11-3003792193dpl:GroupUndertakingscore:ListedExchangeTraded2021-12-012022-11-3003792193core:ListedExchangeTraded2021-12-012022-11-3003792193dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-12-012022-11-3003792193core:UnlistedNon-exchangeTraded2021-12-012022-11-3003792193core:NetGoodwill2023-11-3003792193core:IntangibleAssetsOtherThanGoodwill2023-11-3003792193core:LandBuildings2023-11-3003792193core:PlantMachinery2023-11-3003792193core:Vehicles2023-11-3003792193core:FurnitureFittings2023-11-3003792193core:OfficeEquipment2023-11-3003792193core:AfterOneYear2023-11-3003792193core:WithinOneYear2023-11-3003792193core:ListedExchangeTraded2023-11-3003792193core:UnlistedNon-exchangeTraded2023-11-3003792193core:ShareCapital2023-11-3003792193core:SharePremium2023-11-3003792193core:RevaluationReserve2023-11-3003792193core:OtherReservesSubtotal2023-11-3003792193core:RetainedEarningsAccumulatedLosses2023-11-3003792193core:NetGoodwill2022-11-3003792193core:IntangibleAssetsOtherThanGoodwill2022-11-3003792193core:LandBuildings2022-11-3003792193core:PlantMachinery2022-11-3003792193core:Vehicles2022-11-3003792193core:FurnitureFittings2022-11-3003792193core:OfficeEquipment2022-11-3003792193core:AfterOneYear2022-11-3003792193core:WithinOneYear2022-11-3003792193core:ListedExchangeTraded2022-11-3003792193core:UnlistedNon-exchangeTraded2022-11-3003792193core:ShareCapital2022-11-3003792193core:SharePremium2022-11-3003792193core:RevaluationReserve2022-11-3003792193core:OtherReservesSubtotal2022-11-3003792193core:RetainedEarningsAccumulatedLosses2022-11-3003792193core:NetGoodwill2021-12-0103792193core:IntangibleAssetsOtherThanGoodwill2021-12-0103792193core:LandBuildings2021-12-0103792193core:PlantMachinery2021-12-0103792193core:Vehicles2021-12-0103792193core:FurnitureFittings2021-12-0103792193core:OfficeEquipment2021-12-0103792193core:AfterOneYear2021-12-0103792193core:WithinOneYear2021-12-0103792193core:ListedExchangeTraded2021-12-0103792193core:UnlistedNon-exchangeTraded2021-12-0103792193core:ShareCapital2021-12-0103792193core:SharePremium2021-12-0103792193core:RevaluationReserve2021-12-0103792193core:OtherReservesSubtotal2021-12-0103792193core:RetainedEarningsAccumulatedLosses2021-12-0103792193core:AfterOneYear2022-12-012023-11-3003792193core:WithinOneYear2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:CostValuation2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3003792193core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3003792193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3003792193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3003792193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3003792193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3003792193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3003792193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3003792193core:Non-currentFinancialInstrumentscore:CostValuation2022-11-3003792193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-3003792193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-3003792193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-3003792193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-3003792193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-3003792193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-3003792193bus:Director12022-12-012023-11-3003792193core:FurnitureFittingsToolsEquipment2022-11-3003792193core:FurnitureFittingsToolsEquipment2023-11-3003792193core:FurnitureFittingsToolsEquipment2022-12-012023-11-30

A.B. CHEMISTS LTD

Registered Number
03792193
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2023

A.B. CHEMISTS LTD
Company Information
for the year from 1 December 2022 to 30 November 2023

Director

Mr B Ampomah

Company Secretary

AMPOMAH, Claire

Registered Address

The Clock Pharmacy 1 Gayton Road
Gaywood
King's Lynn
PE30 4EA

Registered Number

03792193 (England and Wales)
A.B. CHEMISTS LTD
Balance Sheet as at
30 November 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets447,84163,539
47,84163,539
Current assets
Stocks5185,442175,625
Debtors61,069,726899,176
Cash at bank and on hand477,569705,010
1,732,7371,779,811
Creditors amounts falling due within one year7(864,589)(794,844)
Net current assets (liabilities)868,148984,967
Total assets less current liabilities915,9891,048,506
Creditors amounts falling due after one year8(22,183)(31,840)
Provisions for liabilities9(1,871)(1,871)
Net assets891,9351,014,795
Capital and reserves
Called up share capital22
Profit and loss account891,9331,014,793
Shareholders' funds891,9351,014,795
The financial statements were approved and authorised for issue by the Director on 27 August 2024, and are signed on its behalf by:
Mr B Ampomah
Director
Registered Company No. 03792193
A.B. CHEMISTS LTD
Notes to the Financial Statements
for the year ended 30 November 2023

1.Accounting policies
Statutory information
A.B. Chemists Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Fixtures and fittings20
Vehicles25
Office Equipment25
Stocks and work in progress
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
2.Average number of employees

20232022
Average number of employees during the year3029
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 December 221,070,0001,070,000
At 30 November 231,070,0001,070,000
Amortisation and impairment
At 01 December 221,070,0001,070,000
At 30 November 231,070,0001,070,000
Net book value
At 30 November 23--
At 30 November 22--
4.Tangible fixed assets

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 December 2278,42077,28449,13712,125216,966
At 30 November 2378,42077,28449,13712,125216,966
Depreciation and impairment
At 01 December 2277,06520,40045,40010,562153,427
Charge for year33914,22174739115,698
At 30 November 2377,40434,62146,14710,953169,125
Net book value
At 30 November 231,01642,6632,9901,17247,841
At 30 November 221,35556,8843,7371,56363,539
5.Stocks

2023

2022

££
Finished goods185,442175,625
Total185,442175,625
6.Debtors: amounts due within one year

2023

2022

££
Trade debtors / trade receivables561,274546,327
Amounts owed by group undertakings194,62166,969
Other debtors313,831285,880
Total1,069,726899,176
7.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables550,825502,975
Bank borrowings and overdrafts10,00011,265
Taxation and social security40,56234,716
Other creditors263,202245,888
Total864,589794,844
8.Creditors: amounts due after one year

2023

2022

££
Bank borrowings and overdrafts22,18331,840
Total22,18331,840
9.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)1,8711,871
Total1,8711,871
10.Related party transactions
At the yearend, Bampnigwe Holding Company Ltd, Benamp Holdings Ltd, Clamp Investment Co Ltd, Spixworth Pharmacy Ltd, Bencas Chemist Ltd, East Harling Chemist Ltd and Alan Stockley & Company Ltd owed £79,887 (2022: £79,887), £6,009 (2022: £16,009), £154,004 (2022: £26,959), £76,000 (2022: £75,000), £86,379 (2022: £86,150), £20,0000 (2022: £20,000) and £34,607 (2022: £24,000) respectively to A.B. Chemist Ltd. The companies are related as Mr. Benjamin Ampomah is also a director in these companies.